<DOC>
	<DOC>NCT01805934</DOC>
	<brief_summary>The eradication rates of first-line treatment for Helicobacter pylori(Hp) infection are not satisfactory. The study aims to compare the efficacy and safety between quadruple therapy with furazolidone and dual therapy with high doses of amoxicillin as rescue regimens for Hp.</brief_summary>
	<brief_title>Quadruple Therapy Versus Dual Therapy as Rescue Regimens for Helicobacter Pylori Infection</brief_title>
	<detailed_description />
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Furazolidone</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Patients aged from 18 to 80 years, who presented with upper gastrointestinal symptoms and endoscopically proven H. pyloripositive nonulcer dyspepsia, were recruited into the study. patients with peptic ulcer, previous H. pylori eradication treatment, previous gastric surgery, pregnancy, lactation, major systemic diseases, receipt of antisecretory therapy, antibiotics or bismuth in the preceding four weeks, or allergy to any one of the medications in the regimen.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Helicobacter pylori, rescue, quadruple therapyï¼Œdual therapy</keyword>
</DOC>